The relationship between oral contraceptives and breast cancer continues to receive widespread attention, particularly given the substantial incidence of this disease and the high prevalence of oral contraceptive use. Endogenous hormones and reproductive factors have been implicated in the aetiology of breast cancer (Kelsey & Hildreth, 1983;Henderson et al., 1982), focusing concern on potential adverse effects of exogenous hormones.Epidemiological studies have consistently shown no overall relationship between the use of oral contraceptives and the risk of developing breast cancer (Trapido, 1981;Kay, 1981;Kelsey et al., 1981;Brinton et al., 1982; CDC, 1983;Vessey et al., 1983;Henneken et al., 1984;Rosenberg et al., 1984;Sattin et al., 1986; LaVecchia et al., 1986;Lipnick et al., 1986;Paul et al., 1986;Schlesselman et al., 1988), although some investigators have reported risk elevations among certain subgroups of exposed women. In particular, there is evidence that oral contraceptives may alter the risk of breast cancer in women with a family history of breast cancer (Black et al., 1980;Brinton et al., 1982), women with prior benign breast lesions (Fasal & Paffenbarger, 1975, 1977Lees et al., 1978;Brinton et al., 1982;Janerich et al., 1983), young women with extended periods of use before a first live birth (Paffenbarger et al., 1977(Paffenbarger et al., , 1980Pike et al., 1981;Harris et al., 1982;McPherson et al., 1983McPherson et al., , 1987Meirik et al., 1986) or before age 25 (Pike et al., 1983;Olsson et al., 1985;Meirik et al., 1986), women under 35 years of age at diagnosis (Kay & Hannaford, 1988) and older women who used oral contraceptives around the perimenopausal period (Vessey et al., 1979;Jick et al., 1980;Paffenbarger et al., 1980;Kay, 1981;Brinton et al., 1982;Henneken et al., 1984 .The present analysis was designed to address the relationship between oral contraceptive use and breast cancer risk in an expanded case-control study. Initial results from this study, based on the first 4 years of a mammography screening programme, were published in 1982 (Brinton et al., 1982). Since that time, the study was expanded to include cases identified through the final 3 years of the screening programme. In addition, oral contraceptive effects were evaluated according to the stage of disease at breast cancer diagnosis.
Materials and methodsStudy subjects were women enrolled in a nationwide breast cancer screening programme, the Breast Cancer Detection Demonstration Project (BCDDP), jointly sponsored by the National Cancer Institute and the American Cancer Society. Details of the study population and methodology have been described elsewhere (Brinton et al., 1983(Brinton et al., , 1986a. Briefly, participants in the BCDDP were recruited between 1973 and 1975, and followed through 1980 for a 5-year programme of annual breast examinations. Cases for the present analysis were all women who were diagnosed with breast cancer during the screening period. The initial phase of the study was conducted among women diagno...